نانولیپوزوم های دارورسان در درمان موثر سرطان پستان

[1]

6287. Shanmugam, S. Selvakumar, C.S. Yeh, Near Infrared light responsive nanomaterials in cancer therapeutics, Chem. Soc. Rev. 43 (2014) 6254–6287. doi:10.1039/c4cs00011k.

[2]          Y. Li, X. Li, A. Doughty, C. West, L. Wang, F. Zhou, R.E. Nordquist, W.R. Chen, Phototherapy using immunologically modified carbon nanotubes to potentiate checkpoint blockade for metastatic breast cancer, Nanomedicine Nanotechnology, Biol. Med. 18 (2019) 44–53. doi:10.1016/j.nano.2019.02.009.

[3]          M. Fu, W. Tang, J.J. Liu, X.Q. Gong, L. Kong, X.M. Yao, M. Jing, F.Y. Cai, X.T. Li, R.J. Ju, Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer, J. Drug Target. 28 (2020) 245–258. doi:10.1080/1061186X.2019.1656725.

[4]          J. Vyas, J.H. Patel, R.N. Patel, Receptor Targeting Liposomal Nano Formulations for Drug Delivery in Breast Cancer, PharmaTutor. 7 (2019) 1–9.

[5]          M. V. Yezhelyev, X. Gao, Y. Xing, A. Al-Hajj, S. Nie, R.M. O’Regan, Emerging use of nanoparticles in diagnosis and treatment of breast cancer, Lancet Oncol. 7 (2006) 657–667. doi:10.1016/S1470-2045(06)70793-8.

[6]          Z.Q. Xu, Q.Q. Yang, J.Y. Lan, J.Q. Zhang, W. Peng, J.C. Jin, F.L. Jiang, Y. Liu, Interactions between carbon nanodots with human serum albumin and γ-globulins: The effects on the transportation function, J. Hazard. Mater. 301 (2016) 242–249. doi:10.1016/j.jhazmat.2015.08.062.

[7]          S. Asfia, M. Mohammadian, H. Kouchakzadeh, Polymeric nanoparticulates as efficient anticancer drugs delivery systems, in: M. Rahmandoust, M. reza Ayatollahi (Eds.), Nanomater. Adv. Biol. Appl., Springer International Publishing, 2019: pp. 55–84. doi:10.1007/978-3-030-10834-2_3.

[8]          J. Lao, J. Madani, T. Puértolas, M. Álvarez, A. Hernández, R. Pazo-Cid, Á. Artal, A. Antón Torres, Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review, J. Drug Deliv. 2013 (2013) 456409:1–12. doi:10.1155/2013/456409.

[9]          C. Zylberberg, S. Matosevic, Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape, Drug Deliv. 23 (2016) 3319–3329. doi:10.1080/10717544.2016.1177136.

[10]        G. Sharma, S. Anabousi, C. Ehrhardt, M.N.V. Ravi Kumar, Liposomes as targeted drug delivery systems in the treatment of breast cancer, J. Drug Target. 14 (2006) 301–310. doi:10.1080/10611860600809112.

[11]        م. گودرزوند, ز. عطائی, نانوسامانه‌های دارویی و لیپوزوم‌ها, نشریه علمی پژوهشی دانشگاه علوم پزشکی البرز. 7 (1397) 220–232. doi:10.29252/aums.7.3.220.

[12]        H. Pandey, R. Rani, V. Agarwal, Liposome and their applications in cancer therapy, Brazilian Arch. Biol. Technol. 59 (2016) 16150477:1–10. doi:10.1590/1678-4324-2016150477.

[13]        H. Daraee, A. Etemadi, M. Kouhi, S. Alimirzalu, H. Daraee, A. Etemadi, M. Kouhi, S. Alimirzalu, A. Akbarzadeh, Application of liposomes in medicine and drug delivery Application of liposomes in medicine and drug delivery, Artif. Cells, Nanomedicine, Biotechnol. 44 (2016) 381–391. doi:10.3109/21691401.2014.953633.

[14]        J. Zhang, Y. Luo, X. Zhao, X. Li, K. Li, D. Chen, M. Qiao, H. Hu, X. Zhao, Co-delivery of doxorubicin and the traditional Chinese medicine quercetin using biotin-PEG2000-DSPE modified liposomes for the treatment of multidrug resistant breast cancer, RSC Adv. 6 (2016) 113173–113184. doi:10.1039/c6ra24173e.

[15]        H. Kouchakzadeh, T. Soudi, N.H. Aghda, S.A. Shojaosadati, Ligand-modified Biopolymeric Nanoparticles as Efficient Tools for Targeted Cancer Therapy, Curr. Pharm. Des. 23 (2017) 5336–5348. doi:10.2174/1381612823666170526101408.

[16]        J.O. Eloy, M. Claro de Souza, R. Petrilli, J.P.A. Barcellos, R.J. Lee, J.M. Marchetti, Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery, Colloids Surfaces B Biointerfaces. 123 (2014) 345–363. doi:10.1016/j.colsurfb.2014.09.029.

[17]        A. Akbarzadeh, R. Rezaei-Sadabady, S. Davaran, S.W. Joo, N. Zarghami, Y. Hanifehpour, M. Samiei, M. Kouhi, K. Nejati-Koshki, Liposome : classification , prepNew aspects of liposomesaration , and applications, Nanoscale Res. Lett. 8 (2013) 102. doi:10.1186/1556-276X-8-102.

[18]        ا. مقیمی پور, م. کوچک, ر. بهمندار, نانولیپوزوم ها به عنوان حامل های دارورسان جدید, مجله علمی پزشکی جندی شاپور. 12 (1392) 467–483.

[19]        R. Tanbour, A. M. Martins, W. G. Pitt, G. A. Husseini, Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review, Curr. Pharm. Des. 22 (2016) 2796–2807. doi:10.2174/1381612822666160217125215.

[20]        Y. Sun, X. Li, L. Zhang, X. Liu, B. Jiang, Z. Long, Y. Jiang, Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer, Mol. Pharm. 16 (2019) 1140–1155. doi:10.1021/acs.molpharmaceut.8b01123.

[21]        J.W. Park, Liposome-based drug delivery in breast cancer treatment, Breast Cancer Res. 4 (2002) 95–99. doi:10.1186/bcr432.